Induction Therapy in the Current Immunosuppressive Therapy
The current immunosuppressive therapy including calcineurin inhibitors, mycophenolate mofetil, and steroids, has substantially suppress rejections and improved clinical outcomes in heart transplant (HTx) recipients. Nevertheless, the management of drug-related nephrotoxicity, fatal acute cellular re...
Guardado en:
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Capítulo de libro |
| Lenguaje: | inglés |
| Publicado: |
IntechOpen
2022
|
| Materias: | |
| Acceso en línea: | https://www.intechopen.com/chapters/81057 |
| Etiquetas: |
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares: Induction Therapy in the Current Immunosuppressive Therapy
- Diagnostic Intravascular Imaging Modalities for Cardiac Allograft Vasculopathy
- Cellular Therapies for Immunosuppression
- Immunosuppressive Therapy After Cardiac Transplantation
- Desensitization and Induction Immunosuppressive Therapy in Highly HLA-Sensitized Patients Receiving Cadaveric Renal Allograft)
- Current Immunosuppression in Abdominal Organ Transplantation
- Treatment of Pediatric-Onset Lupus Nephritis: A New Option of Less Cytotoxic Immunosuppressive Therapy